Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test provides an initial screen of factor XIII activity in your blood. Factor XIII is an enzyme that strengthens and stabilizes a forming blood clot by cross-linking fibrin, the protein strands that make up the clot. Without enough working factor XIII, clots can form but may break down too easily, which can lead to delayed or recurrent bleeding and issues with wound healing.
A preliminary activity test gives a rapid assessment of how well factor XIII is functioning. If the screen suggests a problem, your clinician may order more specific tests to measure factor XIII precisely or to determine whether the A or B subunit is affected.
Clinicians order this test when there is unexplained bleeding, easy bruising, poor wound healing, or bleeding that recurs after seeming to stop. It is also considered for people with a family history of factor XIII deficiency, for those with recurrent pregnancy loss or umbilical stump bleeding in infancy, and before procedures where secure clotting is important. In acquired conditions, such as serious liver disease, immune-mediated inhibitors, or after massive transfusion, factor XIII levels and function can be reduced.
Results help guide next steps, which can include confirmatory assays, genetic testing for inherited deficiency, or treatment decisions such as factor XIII concentrate replacement. Monitoring may also be used to check response to therapy or to plan timing of procedures.
If your result suggests reduced factor XIII activity, your clinician may confirm with a specific activity assay or tests that look at the individual subunits. Some people have an acquired deficiency due to an antibody or an underlying illness, which requires different treatment from inherited deficiency. If the preliminary screen is normal but bleeding symptoms continue, more detailed testing can still be appropriate.
Medications, recent transfusions, or an active illness can influence results, so your clinician will interpret your test in the context of your history and exam. You may be asked to repeat testing, adjust medicines, or see a hematology specialist. Prompt follow-up is important if you have ongoing bleeding, are pregnant, or are planning surgery.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Incorrect tube fill, prolonged tourniquet time, delayed processing, or improper storage of citrate plasma can affect clot-based screening and activity assays for factor XIII.
Recent factor XIII concentrate, blood products, antifibrinolytics, or anticoagulants can raise or lower apparent activity or interfere with clot-based screens, so timing relative to dosing matters.
Severe liver disease, disseminated intravascular coagulation, sepsis, and major surgery or trauma can lower factor XIII and change results, especially during acute illness.
Inherited factor XIII A or B subunit defects can cause lifelong bleeding symptoms. Family history, prior bleeding, and genetic testing help clarify the diagnosis.
Physiologic changes and acquired inhibitors can alter factor XIII activity. Low levels can be linked to miscarriage or postpartum bleeding and may require specialist care.
Newborns and infants can have different baseline levels compared with adults, and age-appropriate interpretation may be needed when assessing results.
References